IP Verse

Oral Pharmaceutical Composition - EP2815753

The patent EP2815753 was granted to Taiho Pharmaceutical on Nov 5, 2025. The application was originally filed on Feb 14, 2013 under application number EP13749171A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2815753

TAIHO PHARMACEUTICAL
Application Number
EP13749171A
Filing Date
Feb 14, 2013
Status
Patent Maintained As Amended
Oct 3, 2025
Publication Date
Nov 5, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSFeb 18, 2019D YOUNGADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2006080327
DESCRIPTIONWO9630346
INTERNATIONAL-SEARCH-REPORTJP2001131075
INTERNATIONAL-SEARCH-REPORTJP2005112744
INTERNATIONAL-SEARCH-REPORTJP2005314413
INTERNATIONAL-SEARCH-REPORTJP2007284390
INTERNATIONAL-SEARCH-REPORTJPH11322604
INTERNATIONAL-SEARCH-REPORTWO2006080327
INTERNATIONAL-SEARCH-REPORTWO9630346
OPPOSITIONEP1849470
OPPOSITIONUS7166301
SEARCHEP2005962
SEARCHUS2006167031

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Charles R., "Evaluation of a Partially Pregelatinized Starch in Comparison with Superdisintegrants a Direct-Compression Hydrochlorothiazide Formulation", Colorcon, pages 1 - 6, XP055569698
OPPOSITION- Raymond C Rowe et al, "Handbook of pharmaceutical excipients", (20090000), pages 424 - 428, XP055569705
SEARCH- EMURA TOMOHIRO ET AL, "Potentiation of the antitumor activity of .alpha., .alpha., .alpha.-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo", INTERNATIONAL JOURNAL OF ONCOLOGY, DEMETRIOS A. SPANDIDOS ED. & PUB, GR, (20050101), vol. 27, no. 2, ISSN 1019-6439, pages 449 - 455, XP009140485 [A] 1-9 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents